Cargando…
Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
BACKGROUND & AIMS: Oropharyngeal and esophageal squamous cell carcinomas, especially the latter, are a lethal disease, featuring intratumoral cancer cell heterogeneity and therapy resistance. To facilitate cancer therapy in personalized medicine, three-dimensional (3D) organoids may be useful fo...
Autores principales: | Kijima, Takashi, Nakagawa, Hiroshi, Shimonosono, Masataka, Chandramouleeswaran, Prasanna M., Hara, Takeo, Sahu, Varun, Kasagi, Yuta, Kikuchi, Osamu, Tanaka, Koji, Giroux, Veronique, Muir, Amanda B., Whelan, Kelly A., Ohashi, Shinya, Naganuma, Seiji, Klein-Szanto, Andres J., Shinden, Yoshiaki, Sasaki, Ken, Omoto, Itaru, Kita, Yoshiaki, Muto, Manabu, Bass, Adam J., Diehl, J. Alan, Ginsberg, Gregory G., Doki, Yuichiro, Mori, Masaki, Uchikado, Yasuto, Arigami, Takaaki, Avadhani, Narayan G., Basu, Devraj, Rustgi, Anil K., Natsugoe, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260338/ https://www.ncbi.nlm.nih.gov/pubmed/30510992 http://dx.doi.org/10.1016/j.jcmgh.2018.09.003 |
Ejemplares similares
-
The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
por: Shimonosono, Masataka, et al.
Publicado: (2018) -
A case report of curative distal gastrectomy for stage IV gastric cancer after chemoradiotherapy in a patient with a gastrojejunal gastric bypass
por: Shimonosono, Masataka, et al.
Publicado: (2016) -
Successful conservative treatment of spontaneous intrathoracic esophageal perforation using a temporary covered esophageal stent with a check valve: a case report
por: Matsumoto, Ryu, et al.
Publicado: (2019) -
Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
por: Tamotsu, Kiyokazu, et al.
Publicado: (2015) -
Programmed death‐ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer
por: Amatatsu, Masahiko, et al.
Publicado: (2018)